218 related articles for article (PubMed ID: 19618115)
1. Directed evolution of adeno-associated virus for glioma cell transduction.
Maguire CA; Gianni D; Meijer DH; Shaket LA; Wakimoto H; Rabkin SD; Gao G; Sena-Esteves M
J Neurooncol; 2010 Feb; 96(3):337-47. PubMed ID: 19618115
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
3. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
Yang L; Jiang J; Drouin LM; Agbandje-McKenna M; Chen C; Qiao C; Pu D; Hu X; Wang DZ; Li J; Xiao X
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3946-51. PubMed ID: 19234115
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
5. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
6. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
7. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
8. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
[TBL] [Abstract][Full Text] [Related]
9. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
[TBL] [Abstract][Full Text] [Related]
11. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
[TBL] [Abstract][Full Text] [Related]
12. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Yang L; Li J; Xiao X
Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
[TBL] [Abstract][Full Text] [Related]
13. Characterization of tissue tropism determinants of adeno-associated virus type 1.
Hauck B; Xiao W
J Virol; 2003 Feb; 77(4):2768-74. PubMed ID: 12552020
[TBL] [Abstract][Full Text] [Related]
14. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
Woodard KT; Liang KJ; Bennett WC; Samulski RJ
J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
[TBL] [Abstract][Full Text] [Related]
15. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.
Li W; Asokan A; Wu Z; Van Dyke T; DiPrimio N; Johnson JS; Govindaswamy L; Agbandje-McKenna M; Leichtle S; Redmond DE; McCown TJ; Petermann KB; Sharpless NE; Samulski RJ
Mol Ther; 2008 Jul; 16(7):1252-60. PubMed ID: 18500254
[TBL] [Abstract][Full Text] [Related]
16. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
17. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.
Balaji S; King A; Dhamija Y; Le LD; Shaaban AF; Crombleholme TM; Keswani SG
J Surg Res; 2013 Sep; 184(1):691-8. PubMed ID: 23590866
[TBL] [Abstract][Full Text] [Related]
19. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
[TBL] [Abstract][Full Text] [Related]
20. Chimeric AAV Cap sequences alter gene transduction.
Ward P; Walsh CE
Virology; 2009 Apr; 386(2):237-48. PubMed ID: 19232422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]